View More Recent Stories

Sep 28, 2021 07:30AM Soligenix Announces Accelerated Publication Demonstrating Efficacy and Broad Neutralizing Activity of its COVID-19 Vaccine in Non-Human Primates
Sep 27, 2021 07:30AM Soligenix Invited to Present at the Cantor Fitzgerald Global Healthcare Conference
Sep 16, 2021 08:24AM Soligenix, Inc. (SNGX) to Advance Synthetic Hypericin Development in Psoriasis
Sep 16, 2021 08:22AM Soligenix to Advance Synthetic Hypericin Development in Psoriasis
Sep 9, 2021 07:32AM Soligenix, Inc. (SNGX) Active Ingredient Hypericin Granted FDA Orphan Drug Designation for Treatment of T-cell Lymphoma
Sep 9, 2021 07:30AM FDA Grants Soligenix Orphan Drug Designation for the Treatment of T-cell Lymphoma
Aug 23, 2021 07:30AM Soligenix Announces Publication Demonstrating Successful Formulation and Heat Stabilization of Filovirus Vaccine Platform for Ebola and Marburg Virus Diseases
Aug 18, 2021 08:53AM Soligenix (SNGX) Announces Positive Preclinical Data with Multiple Heat Stable Filovirus Vaccine Candidates
Aug 18, 2021 08:52AM Soligenix Announces Positive Preclinical Data with Multiple Heat Stable Filovirus Vaccine Candidates
Aug 13, 2021 07:30AM Soligenix Announces Recent Accomplishments And Second Quarter 2021 Financial Results
Jun 22, 2021 07:30AM HyBryte™ Positive Pivotal Phase 3 FLASH Study Selected for Presentation at the United States Cutaneous Lymphoma Consortium (USCLC) Annual Meeting
Aug 30, 2017 10:00AM Soligenix, Inc. (Nasdaq: SNGX) to Ring The Nasdaq Stock Market Closing Bell
Jun 21, 2016 09:00AM Vista Partners Publishes June 2016 Macroeconomic & Investment Newsletter
Apr 19, 2016 09:30AM Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX)
Jan 6, 2016 09:00AM Vista Partners Publishes January 2016 Newsletter
Dec 18, 2015 09:00AM Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX); Price Target $7.00
Dec 10, 2015 01:20PM What $40 or Less Oil Means to the Economy
Nov 10, 2015 09:00AM What Summer Downturn?
Sep 24, 2015 09:00AM Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX); Price Target $7.00
Sep 15, 2015 12:20PM Should We Believe the Fed Will Not Raise Rates in 2015?
Jul 7, 2015 09:00AM Vista Partners Publishes July 2015 Macroeconomic & Investment Newsletter
Jun 23, 2015 07:15AM Soligenix Announces Collaboration with the National Organization for Rare Disorders and the Cutaneous Lymphoma Foundation in Advancing its Phase 3 Study of SGX301 for the Treatment of Cutaneous T-Cell
May 21, 2015 09:00AM Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX); Price Target $7.00
May 13, 2015 09:00AM Vista Partners Publishes May 2015 Macroeconomic & Investment Newsletter
Apr 8, 2015 08:00AM Vista Partners Publishes April 2015 Macroeconomic & Investment Newsletter
Mar 6, 2015 11:15AM Vista Partners Publishes March 2015 Macroeconomic & Investment Newsletter
View More Recent Stories